Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
GSK plc

Start price
Target price
Perf. (%)
€14.42
04.03.21
€21.55
04.03.22
26.39%
05.03.22

Could be worthwhile Investment >10% per year
Very high dividend yield expected
Fair valuation
ROE higher than 10% per year
buy
AstraZeneca plc

Start price
Target price
Perf. (%)
€79.50
02.03.21
€100.00
02.03.22
41.13%
03.03.22

NanoViricides Inc.

Start price
Target price
Perf. (%)
€7.75
02.03.21
-
-41.68%
08.03.21

buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€27.99
01.03.21
€65.00
01.03.22
-58.84%
02.11.21

buy
Zoetis Inc. A

Start price
Target price
Perf. (%)
€130.34
27.02.21
-
27.02.22
37.81%
20.01.22

Innovative
Medium risks for its business
Top 10 in its market
Future proof or reliable business model
buy
GW Pharmaceuticals plc ADR

Start price
Target price
Perf. (%)
€178.00
26.02.21
-
26.02.22
2.81%
29.05.21

buy
Intercept Pharmaceuticals

Start price
Target price
Perf. (%)
€18.24
26.02.21
-
-6.11%
08.03.21

buy
Incyte Corp.

Start price
Target price
Perf. (%)
€64.63
25.02.21
€70.00
3.84%
08.03.21

Could be worthwhile Investment >10% per year
Organigram Holdings Inc.

Start price
Target price
Perf. (%)
€10.48
25.02.21
-
25.02.22
-18.82%
04.05.21

Jounce Therapeutics Inc

Start price
Target price
Perf. (%)
€8.90
25.02.21
-
25.02.22
-27.53%
22.05.21

Incyte Corp.

Start price
Target price
Perf. (%)
€67.64
24.02.21
-
24.02.22
-12.39%
25.11.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Dependend from some customers or products
buy
AbbVie Inc.

Start price
Target price
Perf. (%)
€89.78
24.02.21
-
24.02.22
9.20%
07.07.21

buy
MagForce AG

Start price
Target price
Perf. (%)
€4.62
24.02.21
€9.00
24.02.22
-50.00%
25.02.22

buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€52.05
24.02.21
-
24.02.22
4.61%
06.03.21

buy
Heat Biologics Inc.

Start price
Target price
Perf. (%)
€6.84
23.02.21
-
23.02.22
-35.23%
12.11.21

buy
Viracta Therapeutics Inc.

Start price
Target price
Perf. (%)
€15.09
23.02.21
-
23.02.22
18.33%
24.02.21

Innovative
Could be worthwhile Investment >10% per year
Good culture
No uniques
buy
Vaxart Inc.

Start price
Target price
Perf. (%)
€5.10
23.02.21
-
0.98%
08.03.21

buy
Organigram Holdings Inc.

Start price
Target price
Perf. (%)
€10.93
22.02.21
€100.00
22.02.22
-36.55%
12.12.21

buy
Hexo Corp.

Start price
Target price
Perf. (%)
€87.57
22.02.21
-
22.02.22
-86.35%
12.12.21

Could be very worthwhile Investment >20% year
Very Future proof/growth oriented business model
buy
Astrazeneca ADR

Start price
Target price
Perf. (%)
€41.40
22.02.21
-
22.02.22
0.00%
10.03.21

Could be worthwhile Investment >10% per year
Medium risks for its business
Small cyclical dependencies
buy
Celsion Corp.

Start price
Target price
Perf. (%)
€35.70
22.02.21
€60.00
22.02.22
-37.40%
06.03.21

Could be worthwhile Investment >10% per year
Good culture
Leading role in innovation
high free float
buy
Paion AG

Start price
Target price
Perf. (%)
€2.39
22.02.21
€4.00
22.02.22
-22.85%
05.11.21

Aphria Inc.

Start price
Target price
Perf. (%)
€16.95
22.02.21
-
22.02.22
-21.81%
06.03.21

Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€60.00
21.02.21
-
-46.65%
26.02.21

Could be very worthwhile Investment >20% year
buy
Sarepta Therapeutics

Start price
Target price
Perf. (%)
€71.43
21.02.21
€78.00
-3.43%
22.03.21